Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SH3809 |
| Synonyms | |
| Therapy Description |
SH3809 is a PTPN11 (SHP2) inhibitor, which potentially blocks MAPK signaling leading to tumor growth inhibition (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SH3809 | SH 3809|SH-3809 | SHP2 Inhibitor 20 | SH3809 is a PTPN11 (SHP2) inhibitor, which potentially blocks MAPK signaling leading to tumor growth inhibition (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|